Find a Clinical Trial

15 search results

Dermatology

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

Location: Lebanon

A Phase 3, Multicenter, Long-Term Extension Study to Assess the Safety and Efficacy of Lebrikizumab in Participants 6 Months to <18 Years of Age with Moderate-to-Severe Atopic Dermatitis

Location: Lebanon

A randomized, double-blind, placebo-controlled, phase 3 study to assess the efficacy, safety and pharmacokinetics of Lebrikizumab compared to placebo in participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis.

Location: Lebanon

Characterizing Microbiomes in Cutaneous Diseases

Location: Lebanon

Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study

Location: Lebanon

Comparison of Compounded Topical Anesthetics for Pain Relief of Intense Pulsed Light, Pulse Dye Laser Treatments and Microneedling

Location: Lebanon

Cost Analysis of TeleDermatology and Conventional Dermatology Visits

Location: Lebanon

DERMATOLOGY RESIDENT COMFORT LEVEL USING LASERS AND COSMETIC TREATMENTS IN TREATING SKIN OF COLOR

Location: Lebanon

Evaluation of Treatment Response to Neoadjuvant Immunotherapy in Patients with Cutaneous Tumors

Location: Lebanon

Expert consensus on the use of combination 5-fluorouracil and calcipotriene for the treatment and prevention of non-melanoma skin cancer and actinic keratoses

Location: Lebanon

Incidence of acne vulgaris associated with progestin-releasing intrauterine devices (IUDs) (working title)

Location: Lebanon

Patient Experience Survey on The Impact of Using Non-Steroidal Anti-Inflammatory Medications on Their Hidradenitis Suppurativa Skin Condition

Location: Lebanon

Prospective study for Development and Optimization of CRISPER Point of Care Test for Identification of Dermatophytes in Onychomycosis

Location: Lebanon

Quality of Life Survey in Patients with Down Syndrome and Dermatologic Conditions

Location: Lebanon

Study M20-465 Hidradenitis Suppurativa: Lutikizumab in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa

Location: Lebanon